z-logo
open-access-imgOpen Access
Efficacy of entecavir verses lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with allogeneic stem cell transplant
Author(s) -
Dexton Antony Johns
Publication year - 2021
Publication title -
annals of hepato-biliary-pancreatic surgery
Language(s) - English
Resource type - Journals
eISSN - 2508-5859
pISSN - 2508-5778
DOI - 10.14701/ahbps.ep-89
Subject(s) - entecavir , lamivudine , medicine , virology , stem cell , hepatitis a virus , hepatitis b virus , immunology , virus , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom